Related Experiment Video
Updated: Jun 26, 2026
06:33
Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells
Published on: February 2, 2024
Stem cell sources to treat diabetes.
1Department of Urology and Wake Forest, Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
Journal of Cellular Biochemistry
|January 9, 2009
Summary
Stem cells are being engineered into pancreatic beta-cells for diabetes therapy. While promising, challenges like teratoma formation and immune rejection need solutions for widespread clinical use.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Endocrinology
Background:
- Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia.
- Pancreatic beta-cells are crucial for insulin production and glucose regulation.
- Current diabetes therapies have limitations, driving the need for novel approaches.
Purpose of the Study:
- To review the progress in using stem cells for engineered pancreatic beta-cell therapy.
- To identify current challenges and potential alternative strategies for diabetes treatment.
Main Methods:
- Review of in vitro differentiation protocols for embryonic stem (ES) cells and induced pluripotent stem (iPS) cells.
- Analysis of studies on the in vivo function of stem cell-derived beta-like cells.
- Evaluation of alternative stem cell sources and strategies to overcome transplantation hurdles.
Main Results:
- ES and iPS cells can differentiate into insulin-producing beta-like cells, but with low efficiency and incomplete glucose responsiveness.
- Transplanted human ES-derived pancreatic endoderm cells showed potential for blood sugar regulation in mice.
- Teratoma formation and the need for immunosuppression remain significant obstacles for clinical translation.
Conclusions:
- Stem cell-derived beta-like cells show promise for diabetes therapy, but further research is needed to address safety and efficacy.
- Alternative stem cell sources (e.g., amniotic fluid-derived, hepatic stem cells) and strategies like HLA-homozygous cell banking warrant investigation.
- Overcoming hurdles like teratoma formation, immune rejection, and cost is essential for clinical application.
More Related Videos
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.